The DYN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DYN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The DYN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View DYN Detailed Price Forecast - CNN Money | View DYN Detailed Summary - Google Finance | ||
View DYN Detailed Summary - Yahoo! Finance | View DYN Stock Research & Analysis - Zacks.com |
View DYN Trends & Analysis - Trade-Ideas | View DYN Major Holders - Barrons | ||
View DYN Call Transcripts - NASDAQ | View DYN Breaking News & Analysis - Seeking Alpha | ||
View DYN Annual Report - CompanySpotlight.com | View DYN OTC Short Report - OTCShortReport.com | ||
View DYN Fundamentals - TradeKing | View DYN SEC Filings - Bar Chart | ||
View Historical Prices for DYN - The WSJ | View Performance/Total Return for DYN - Morningstar | ||
View the Analyst Estimates for DYN - MarketWatch | View the Earnings History for DYN - CNBC | ||
View the DYN Earnings - StockMarketWatch | View DYN Buy or Sell Recommendations - MacroAxis | ||
View the DYN Bullish Patterns - American Bulls | View DYN Short Pain Metrics - ShortPainBot.com |
View DYN Stock Mentions - StockTwits | View DYN Stock Mentions - PennyStockTweets | ||
View DYN Stock Mentions - Twitter | View DYN Investment Forum News - Investor Hub | ||
View DYN Stock Mentions - Yahoo! Message Board | View DYN Stock Mentions - Seeking Alpha |
View Insider Transactions for DYN - SECform4.com | View Insider Transactions for DYN - Insider Cow | ||
View DYN Major Holdings Summary - CNBC | View Insider Disclosure for DYN - OTC Markets | ||
View Insider Transactions for DYN - Yahoo! Finance | View Institutional Holdings for DYN - NASDAQ |
View DYN Stock Insight & Charts - FinViz.com | View DYN Investment Charts - StockCharts.com | ||
View DYN Stock Overview & Charts - BarChart | View DYN User Generated Charts - Trading View |
Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
Posted on Wednesday March 27, 2024
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that it has granted an inducement equity award to its newly appointed President and Chief Executive Officer, John G. Cox. The award was approved by the Compensation Committee of Dyne and was made as an inducement material to Mr. Cox’s acce
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
Posted on Wednesday March 27, 2024
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that Wildon Farwell, M.D., MPH, chief medical officer, and Oxana Beskrovnaya, Ph.D., chief scientific officer, are scheduled to participate in a fireside chat during the Cantor Virtual Muscular Dystrophy Symposium on Tuesday, April 2, 2024
Dyne Therapeutics Announces CEO Transition
Posted on Monday March 25, 2024
John Cox John Cox, President and CEO of Dyne Therapeutics - John Cox, Industry Leader with Global Experience in Rare Disease Commercialization, Joins Dyne as President and CEO - WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of John Cox as president, chief executive off
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
Posted on Wednesday March 13, 2024
WALTHAM, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Stifel 2024 Virtual CNS Days on Wednesday, March 20, 2024 at 8:30 a.m. ET. A live webcast will be available in the Investors & Media section of Dyne’s website at https:/